April 23, 2026
MHRA quetiapine specials recall raises traceability and substitution pressures in unlicensed medicine supply
An MHRA recall of Eaststone quetiapine oral suspension puts focus on traceability, pharmacy recall action, and alternative supply for unlicensed specials.
Read insightApril 23, 2026
UK community pharmacy reimbursement reform points to Drug Tariff and specials supply changes
The government’s response keeps all reimbursement reform proposals alive, with potential effects on Drug Tariff pricing, pharmacy cash flow and specials procurement in England.
Read insight